Krishnan, A., Kapoor, P., Palmer, J. M., Tsai, N., Kumar, S., Lonial, S., . . . Berdeja., J. G. (2018). Phase I/II trial of the oral regimen ixazomib, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma. Leukemia.
Style de citation ChicagoKrishnan, Amrita, et al. "Phase I/II Trial of the Oral Regimen Ixazomib, Pomalidomide, and Dexamethasone in Relapsed/refractory Multiple Myeloma." Leukemia 2018.
Style de citation MLAKrishnan, Amrita, et al. "Phase I/II Trial of the Oral Regimen Ixazomib, Pomalidomide, and Dexamethasone in Relapsed/refractory Multiple Myeloma." Leukemia 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.